Trypanosoma cruzi infection results in an increase in intracellular cholesterol

Microbes and Infection

Volumn 16, Issue 4, 2014, Pages 337-344

  Johndrow, Christopher ^b   Nelson, Randin ^a,b   Tanowitz, Herbert ^a,b   Weiss, Louis M ^a,b   Nagajyothi, Fnu ^b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Chagas disease; Cholesterol; Invasion; LDL; Pathogenesis; Trypanosoma cruzi

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CELL LEVEL; CHAGAS DISEASE; CONTROLLED STUDY; EMBRYO; HOMEOSTASIS; HOST CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID STORAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSIENT TRANSFECTION; ANIMAL; CHEMISTRY; CYTOPLASM; DISEASE MODEL; OXIDATIVE STRESS; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY; TRYPANOSOMA CRUZI;

MURINAE; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; CHOLESTEROL; CYTOPLASM; DISEASE MODELS, ANIMAL; HUMANS; LIPOPROTEINS, LDL; MALE; MICE; OXIDATIVE STRESS; TRYPANOSOMA CRUZI;

EID: 84899479229     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.01.001     Document Type: Article

References (35)

1. Machado F.S., Jelicks L.A., Kirchhoff L.V., Shirani J., Nagajyothi F., Mukherjee S., et al. Chagas heart disease: report on recent developments. Cardiol Rev 2012, 20:53-65.
2. Valdez R.H., Tonin L.T.D., Ueda-Nakamura T., Silva S.O., Dias Filho B.P., Kaneshima E.N., et al. Invitro and invivo trypanocidal synergistic activity of N-butyl-1-(4-dimethylamino) phenyl-1, 2, 3, 4-tetrahydro-β-carboline-3-carboxamide associated with benznidazole. Antimicrobial Agents Chemother 2012, 56:507-512.
3. Klein N., Hurwitz I., Durvasula R. Globalization of Chagas disease: a growing concern in nonendemic countries. Epidemiol Res Int 2012, 2012.
4. Meurs K.M., Anthony M.A., Slater M., Miller M.W. Chronic Trypanosoma cruzi infection in dogs: 11 cases (1987-1996). J Am Vet Med Assoc 1998, 213:497-500.
5. Bradley K.K., Bergman D.K., Woods J.P., Crutcher J.M., Kirchhoff L.V. Prevalence of American trypanosomiasis (Chagas disease) among dogs in Oklahoma. J Am Vet Med Assoc 2000, 217:1853-1857.
6. Beard C.B., Pye G., Steurer F.J., Rodriguez R., Campman R., Peterson A.T., et al. Chagas disease in a domestic transmission cycle, southern Texas, USA. Emerg Infect Dis 2003, 9:103-105.
7. Yabsley M.J., Noblet G.P. Seroprevalence of Trypanosoma cruzi in raccoons from South Carolina and Georgia. J Wildl Dis 2002, 38:75-83.
8. Tanowitz H.B., Huang H., Jelicks L.A., Chandra M., Loredo M.L., Weiss L.M., et al. Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease. Infect Immun 2005, 73:2496-2503.
9. Tanowitz H.B., Machado F.S., Jelicks L.A., Shirani J., de Carvalho A.C., Spray D.C., et al. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis 2009, 51:524-539.
10. Machado F.S., Martins G.A., Aliberti J.C., Mestriner F.L., Cunha F.Q., Silva J.S. Trypanosoma cruzi - infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 2000, 102:3003-3008.
11. Ba X., Gupta S., Davidson M., Garg N.J. Trypanosoma cruzi induces the reactive oxygen species-PARP-1-RelA pathway for up-regulation of cytokine expression in cardiomyocytes. J Biol Chem 2010, 285:11596-11606.
12. Gomes J.A., Bahia-Oliveira L.M., Rocha M.O., Busek S.C., Teixeira M.M., Silva J.S., et al. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun 2005, 73:7960-7966.
13. Hassan G.S., Mukherjee S., Nagajyothi F., Weiss L.M., Petkova S.B., de Almeida C.J., et al. Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells. Infect Immun 2006, 74:152-159.
14. dos Santos V.M., de Lima M.A., Cabrine-Santos M., de Stefani Marquez D., de Araújo Pereira G., Lages-Silva E., et al. Functional and histopathological study of the pancreas in hamsters (Mesocricetus auratus) infected and reinfected with Trypanosoma cruzi. Parasitol Res 2004, 94:125-133.
15. Barrias E.S., Reignault L.C., De Souza W., Carvalho T.M. Trypanosoma cruzi uses macropinocytosis as an additional entry pathway into mammalian host cell. Microbes Infect 2012, 14:1340-1351.
16. Bouzahzah B., Yurchenko V., Nagajyothi F., Hulit J., Sadofsky M., Braunstein V.L., et al. Regulation of host cell cyclin D1 by Trypanosoma cruzi in myoblasts. Cell Cycle 2008, 7:500-503.
17. Nagajyothi F., Weiss L.M., Silver D.L., Desruisseaux M.S., Scherer P.E., Herz J., et al. Trypanosoma cruzi utilizes the host low density lipoprotein receptor in invasion. PLoS Negl Trop Dis 2011, 5:e953.
18. Rodríguez A., Samoff E., Rioult M., Chung A., Andrews N.W. Host cell invasion by trypanosomes requires lysosomes and microtubule/kinesin-mediated transport. J Cell Biol 1996, 134:349-362.
19. Wilkowsky S.E., Barbieri M.A., Stahl P., Isola E.L.D. Trypanosoma cruzi: phosphatidylinositol 3-Kinase and protein kinase B activation is associated with parasite invasion. Exp Cell Res 2001, 264:211-218.
20. Prioli R.P., Rosenberg I., Pereira M.E. High- and low-density lipoproteins enhance infection of Trypanosoma cruzi invitro. Mol Biochem Parasitol 1990, 15:191-198.
21. Combs T.P., Nagajyothi F., Mukherjee S., de Almeida C.J., Jelicks L.A., Schubert W., et al. The adipocyte as an important target cell for Trypanosoma cruzi infection. J Biol Chem 2005, 280:24085-24094.
22. Nagajyothi F., Desruisseaux M.S., Machado F.S., Upadhya R., Zhao D., Weiss L.M., et al. Response of adipose tissue to early infection with Trypanosoma cruzi (Brazil strain). J Infect Dis 2012, 205:830-840.
23. Ferreira A.V., Segatto M., Menezes Z., Macedo A.M., Gelape C., de Oliveira Andrade L., et al. Evidence for Trypanosoma cruzi in adipose tissue in human chronic Chagas disease. Microbes Infect 2011, 13:1002-1005.
24. Nagajyothi F., Zhao D., Machado F.S., Weiss L.M., Schwartz G.J., Desruisseaux M.S., et al. Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection. J Infect Dis 2010, 202:1104-1113.
25. Gary W., Gill B.A. Cytopreparation principles & practice. Essen Cytopathol 2013, 12:207-216.
26. Reid P.C., Sakashita N., Sugii S., Ohno-Iwashita Y., Shimada Y., Hickey W.F., et al. A novel cholesterol stain reveals early neuronal cholesterol accumulation in the Niemann-Pick type C1 mouse brain. J Lipid Res 2004, 45:582-591.
27. Rossi M.A., Tanowitz H.B., Malvestio L.M., Celes M.R., Campos E.C., Blefari V., et al. Coronary microvascular disease in chronic Chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms. PLoS Negl Trop Dis 2010, 4:e674.
28. Morris S.A., Tanowitz H.B., Wittner M., Bilezikian J.P. Pathophysiological insights into the cardiomyopathy of Chagas' disease. Circulation 1990, 82:1900-1909.
29. Petersen C.A., Burleigh B.A. Role for interleukin-1β in Trypanosoma cruzi-induced cardiomyocyte hypertrophy. Infect Immun 2003, 71:4441-4447.
30. Appelqvist H., Nilsson C., Garner B., Brown A.J., Kågedal K., Öllinger K. Attenuation of the lysosomal death pathway by lysosomal cholesterol accumulation. Am J Pathol 2011, 178:629-639.
31. Caradonna K.L., Burleigh B.A. Mechanisms of host cell invasion by Trypanosoma cruzi. Adv Parasitol 2011, 76:33-61.
32. Villalta F., Scharfstein J., Ashton A.W., Tyler K.M., Guan F., Mukherjee S., et al. Perspectives on the Trypanosoma cruzi-host cell receptor interactions. Parasitol Res 2009, 104:1251-1260.
33. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002, 109:1125-1131.
34. Brown M.S., Goldstein J.L. A proteolytic pathway that controls the cholesterol content of membranes, cells and blood. Proc Natl Acad Sci U S A 1999, 96:11041-11048.
35. Caradonna K.L., Engel J.C., Jacobi D., Lee C.H., Burleigh B.A. Host metabolism regulates intracellular growth of Trypanosoma cruzi. Cell Host Microbe 2013, 13:108-117.